Novartis | Driftsresultatet

Operating Profit Endring Dato
AbbVie USD 2.96B 233M 2024-03
Amgen USD 991M 280M 2024-03
AstraZeneca USD 3.12B 1.88B 2024-03
Bausch Health Companies USD 294M 69M 2024-03
Biogen USD 570M 211.1M 2024-03
Bristol-Myers Squibb USD 1.51B 340M 2024-03
Canopy Growth CAD -32810000 28.08M 2024-03
Catalent USD -17000000 95M 2024-03
Corcept Therapeutics USD 29.5M 2.17M 2024-03
Drreddys Laboratories INR 17.27B 600M 2023-12
Eli Lilly USD 2.74B 347.8M 2024-03
Gilead Sciences USD -191000000 1.8B 2024-03
GlaxoSmithKline GBP 1.49B 917M 2024-03
Glaxosmithkline GBP 1.49B 917M 2024-03
J&J USD 6.27B 1.45B 2024-03
Merck USD 5.76B 7.69B 2024-03
Novartis USD 3.37B 791M 2024-03
Novartis USD 3.37B 791M 2024-03
Pacira USD 15.11M 18.05M 2024-03
Perrigo USD -10900000 1.5M 2024-03
Pfizer USD 4.2B 10.75B 2024-03
Prestige Brands USD 82.15M 4.68M 2024-03
Roche Holding CHF 9.76B 3.84B 2023-06
Sanofi EUR 2.23B 980M 2024-03
Sanofi EUR 2.23B 980M 2024-03
Supernus Pharmaceuticals USD -4248000 3.25M 2024-03
Zoetis USD 801M 151M 2024-03



Novartis Driftsresultatet - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.